TISAGENLECLEUCEL for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 72 adverse event reports in the FDA FAERS database where TISAGENLECLEUCEL was used for Diffuse large b-cell lymphoma refractory.

Most Reported Side Effects for TISAGENLECLEUCEL

Side Effect	Reports	%	Deaths	Hosp.
Cytokine release syndrome	1,660	39.3%	505	696
Pyrexia	1,030	24.4%	311	427
Malignant neoplasm progression	582	13.8%	400	126
Hypotension	425	10.1%	156	214
Immune effector cell-associated neurotoxicity syndrome	416	9.8%	127	183
Neurotoxicity	411	9.7%	146	155
Platelet count decreased	397	9.4%	182	77
White blood cell count decreased	392	9.3%	164	59
Hypogammaglobulinaemia	374	8.8%	126	38
Lymphocyte count decreased	365	8.6%	139	38
Acute lymphocytic leukaemia recurrent	361	8.5%	100	71
Neutrophil count decreased	358	8.5%	134	58
Haemoglobin decreased	356	8.4%	175	47
Diffuse large b-cell lymphoma	300	7.1%	229	69
Death	282	6.7%	282	30